← FDA Drug Approvals (Drugs@FDA)

NDA216469

NDA · New Drug Application · Sponsor: COLUMBIA THERAPEUTICS INC · Approved 2025-01-17

Drug application

FDA Application #

NDA216469

Application type

New Drug Application

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

COLUMBIA THERAPEUTICS INC

First approval

2025-01-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown